| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 11/14/2000 | US6146888 Amplification of preferential cell population; mixing cells in which the genome codes an antibiotic resistance gene, recovering cells that propagate in the presence of antibiotic |
| 11/14/2000 | US6146876 22025, a novel human cyclic nucleotide phosphodiesterase |
| 11/14/2000 | US6146867 Methods for expressing a maize acetyl CoA carboxylase gene in host cells and encoded protein produced thereby |
| 11/14/2000 | US6146863 Staphylococcus aureus 3-hydroxyacyl-CoA dehydrogenase |
| 11/14/2000 | US6146855 Method for the detection of viable Cryptosporidium parvum oocysts |
| 11/14/2000 | US6146847 Stabilized transient gene expression |
| 11/14/2000 | US6146846 Primosome protein a of streptococcus pneumoniae |
| 11/14/2000 | US6146845 Polynucleotides encoding a sialoadhesin family member-2 (SAF-2) |
| 11/14/2000 | US6146843 Method and apparatus for the use of sentinel microorganism |
| 11/14/2000 | US6146842 High-throughput screening assays utilizing metal-chelate capture |
| 11/14/2000 | US6146841 Methods for identifying compounds that bind to CSAPK-3 molecules and fragments thereof |
| 11/14/2000 | US6146840 Simultaneous enumeration of E. coli and total coliforms |
| 11/14/2000 | US6146835 Nucleotide sequence; for drug screening of novel analgesics; for recombinant production of receptor |
| 11/14/2000 | US6146834 PCR primers for detection of plant pathogenic species and subspecies of acidovorax |
| 11/14/2000 | US6146832 Protein kinase molecules and uses therefor |
| 11/14/2000 | US6146831 Cellular models for diabetes and other diseases associated with mitochondrial defects |
| 11/14/2000 | US6146830 Drug screening or discovery |
| 11/14/2000 | US6146829 Gapped 2' modified oligonucleotides |
| 11/14/2000 | US6146828 Methods for detecting differences in RNA expression levels and uses therefor |
| 11/14/2000 | US6146827 Detecting nucleic acid involved in g protein mediated signal transduction in a t helper cell sample |
| 11/14/2000 | US6146826 Green fluorescent protein |
| 11/14/2000 | US6146634 Proteins with urease activity |
| 11/14/2000 | US6146627 Method for reducing T cell-mediated cytotoxicity in HIV using anti-idiotypic antibody |
| 11/14/2000 | US6146593 Contacting biosensor comprising optical fibers with first and second collections of labelled nulceic acid molecules; comparing amount of binding to determine relative copy number of any sequences that are complementary |
| 11/14/2000 | US6146589 Assay device for detecting the presence of an analyte involving sequential delivery of reagents through a liquid circuit |
| 11/14/2000 | CA2188933C Apolipoprotein e polymorphism and treatment of alzheimer's disease |
| 11/14/2000 | CA2153103C Process for lysing mycobacteria |
| 11/14/2000 | CA2132271C Improved data collection method for use with chemical sensors |
| 11/14/2000 | CA1341140C Structural phosphoprotein (pp28) of human cytomegalovirus (hcmv), the preparation and use thereof |
| 11/10/2000 | CA2270639A1 A method for measuring biomolecules |
| 11/09/2000 | WO2000067037A2 A combined rapid anti-microbial susceptibility assay and microorganism identification system |
| 11/09/2000 | WO2000067031A1 Method of determining osteoporotic processes |
| 11/09/2000 | WO2000067028A1 Process to create biomolecule arrays on metal surfaces |
| 11/09/2000 | WO2000067027A1 Augmented agglutination assay |
| 11/09/2000 | WO2000067025A1 Determination of complex phospholipid/lipid structures using synthetic fluorescence-marked acylglycerides |
| 11/09/2000 | WO2000067021A1 Products and methods for single parameter and multiparameter phenotyping of cells |
| 11/09/2000 | WO2000067016A1 Methods for the identification of compounds for the treatment of alzheimer's disease |
| 11/09/2000 | WO2000067007A2 Method and apparatus for obtaining electric field-enhanced bioconjugation |
| 11/09/2000 | WO2000066995A2 Device for rapid dna sample processing with integrated liquid handling, thermocycling, and purification |
| 11/09/2000 | WO2000066792A1 Analysis of differential protein expression |
| 11/09/2000 | WO2000066791A1 Neisseria genomic sequences and methods of their use |
| 11/09/2000 | WO2000066789A2 Polynucleotide matrix-based method of identifying microorganisms |
| 11/09/2000 | WO2000066788A2 Polynucleotide probes for detection and quantitation of staphylococcus |
| 11/09/2000 | WO2000066787A2 Growth hormone-regulatable liver genes and proteins, and uses thereof |
| 11/09/2000 | WO2000066786A2 Polynucleotide probes for detection and quantitation of actinomycetes |
| 11/09/2000 | WO2000066785A2 Polynucleotide probes for detection and quantitation of bacteria in the family enterobacteriaceae |
| 11/09/2000 | WO2000066784A2 Growth hormone-regulatable brown adipose tissue genes, corresponding proteins and uses thereof |
| 11/09/2000 | WO2000066783A2 Rapid and efficient capture of dna from sample without using cell lysing reagent |
| 11/09/2000 | WO2000066782A2 Diagnostic assay for diabetes mellitus based on mutational burden |
| 11/09/2000 | WO2000066781A2 Dna balls |
| 11/09/2000 | WO2000066780A2 Adeno-associated virus-delivered ribozyme compositions and methods of use |
| 11/09/2000 | WO2000066779A1 Comparative fluorescence hybridization to oligonucleotide microarrays |
| 11/09/2000 | WO2000066777A2 Assay based on the analysis of dna melting curves |
| 11/09/2000 | WO2000066776A1 Algorithmic testing in laboratory medicine |
| 11/09/2000 | WO2000066775A1 Cyp2a6 gene judgment methods |
| 11/09/2000 | WO2000066774A2 Improved assay and reagents therefor |
| 11/09/2000 | WO2000066773A2 Method of detection of cytochrome b mutations in funghi leading to resistance against anti-fungal agents |
| 11/09/2000 | WO2000066772A1 Method for detecting by dhplc a difference of dna genotype and/or sequence |
| 11/09/2000 | WO2000066771A2 Diagnostic sequencing by a combination of specific cleavage and mass spectrometry |
| 11/09/2000 | WO2000066770A2 Method for producing a chemically and thermally stable solid phase matrix for polymerase chain reaction (pcr) and dna hybridisation assay |
| 11/09/2000 | WO2000066769A2 System and method for screening of nasopharyngeal carcinoma |
| 11/09/2000 | WO2000066768A1 Method of amplification of nucleic acids |
| 11/09/2000 | WO2000066767A1 Estrogen signalling pathway regulators and uses thereof |
| 11/09/2000 | WO2000066766A1 Optical probes and assays |
| 11/09/2000 | WO2000066765A1 Method for the determination of disaccharidases and kit therefor |
| 11/09/2000 | WO2000066764A1 Methods for increasing t cell proliferation |
| 11/09/2000 | WO2000066763A1 Methods, compositions and kits for biological indicator of sterilization |
| 11/09/2000 | WO2000066762A2 Indicators of altered mitochondrial function in predictive methods for determining risk of type 2 diabetes mellitus |
| 11/09/2000 | WO2000066755A2 Pesticidal fusions |
| 11/09/2000 | WO2000066746A1 Herbicide resistant plants |
| 11/09/2000 | WO2000066739A2 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 11/09/2000 | WO2000066736A1 Growth factor homolog zvegf4 |
| 11/09/2000 | WO2000066735A2 Human ion channel proteins |
| 11/09/2000 | WO2000066726A1 Novel cellular regulation factor tto 20 |
| 11/09/2000 | WO2000066722A1 Collection of prokaryotic dna for two hybrid systems helicobacter pylori protein-protein interactions and application thereof |
| 11/09/2000 | WO2000066713A2 Materials and methods relating to neuronal development |
| 11/09/2000 | WO2000066709A2 Zymogen activation system |
| 11/09/2000 | WO2000066708A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 11/09/2000 | WO2000066707A2 Novel thiamine transporter, a polynucleotide encoding same and their uses |
| 11/09/2000 | WO2000066664A1 Aza-benzazolium containing cyanine dyes |
| 11/09/2000 | WO2000066630A1 DNA ENCODING SNORF36a AND SNORF36b RECEPTORS |
| 11/09/2000 | WO2000066623A2 Surrogate cell-based system and method for assaying the activity of hepatitis c virus ns3 protease |
| 11/09/2000 | WO2000066617A1 Methods for the treatment of neuronal atrophy-associated dementia |
| 11/09/2000 | WO2000066615A1 Compositions and methods for detection of active proteases |
| 11/09/2000 | WO2000066607A1 Detection using degradation of a tagged sequence |
| 11/09/2000 | WO2000066605A2 Polynucleotides |
| 11/09/2000 | WO2000066604A2 L-ribo-lna analogues |
| 11/09/2000 | WO2000066266A1 Sensor for microfluid handling system |
| 11/09/2000 | WO2000066181A1 Method of screening for drugs useful in treating alzheimer's disease |
| 11/09/2000 | WO2000066159A1 Method for inhibiting cell functioning for use in anti-inflammatory and anti-tumour therapies |
| 11/09/2000 | WO2000066157A1 Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines |
| 11/09/2000 | WO2000066154A2 Anti-microbial agents, diagnostic reagents, and vaccines based on unique apicomplexan parasite components |
| 11/09/2000 | WO2000066150A1 New use of a substance in pns |
| 11/09/2000 | WO2000066137A1 Asialocytokines and treatment of liver disease |
| 11/09/2000 | WO2000066067A2 Ibd-associated microbial antigens and methods of using same |
| 11/09/2000 | WO2000065908A1 Traf5 knockout mouse |
| 11/09/2000 | WO2000040705A3 Human desaturase gene and uses thereof |
| 11/09/2000 | WO2000040525A3 Polymer arrays and methods of making and using same |
| 11/09/2000 | WO2000039586A3 Tetramethylbenzidine formulation for horseradish peroxidase enzyme assays |
| 11/09/2000 | WO2000037658A3 Chemically modified enzymes with multiple charged variants |